First clinical trial of innovative drug targeting HSF1 pathway begins 31 Dec 2021 The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial. Find out more Show/Hide
Abiraterone could halve risk of prostate cancer death for some patients 23 Dec 2021 Adding abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading*, could halve the risk of death from the disease. Find out more Show/Hide
Cancer trial recruitment drops by 60 per cent during pandemic 09 Dec 2021 The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying the development of cutting-edge drugs and technologies. Find out more Show/Hide
Scientists identify potential new drug combination for children with incurable brain cancer 05 Nov 2021
ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers 11 Oct 2021
ESMO 2021: Abiraterone keeps men with prostate cancer at risk of spreading alive for longer 19 Sep 2021
Shorter radiotherapy courses for prostate cancer are well tolerated long-term by patients 19 Sep 2021